SM

Suryakant Mahadeo Lokhande

Director DIN 05290097
DIN 05290097 First appointment Jun 2012
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jun 2012
Shareholding value β€’β€’β€’β€’ Premium profile

About Suryakant Mahadeo Lokhande

Data last updated:

Suryakant Mahadeo Lokhande was a Director at Adage Lifesciences Private Limited (from 2012) and Director at Winista Life Sciences Private Limited (from 2014).

DIN 05290097
First Appointment 28 Jun 2012
Oldest Company Age 14 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Adage Lifesciences Private Limited U74900PN2012PTC143848
Director28 Jun 20122012Strike Off
Director12 Jun 20142014Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Adage Lifesciences Private Limited
Winista Life Sciences Private Limited
Premium access

Shareholding and investment profile for Suryakant Mahadeo Lokhande

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suryakant Mahadeo Lokhande

Suryakant Mahadeo Lokhande was first appointed on 28 Jun 2012 as Director at Adage Lifesciences Private Limited. The most recent appointment on record is 12 Jun 2014 at Winista Life Sciences Private Limited.

Suryakant Mahadeo Lokhande held 2 earlier board appointments: Adage Lifesciences Private Limited (Director, from 28 Jun 2012); Winista Life Sciences Private Limited (Director, from 12 Jun 2014).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available